Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GSK2190915 in asthmatic patients with elevated sputum neutrophils
NCT01471665Phase 2Completed
- Sponsor
- GSK
- Start
- Jun 2011
- Primary completion
- May 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fiboflapon in asthma, sponsored by GSK. Started Jun 2011; status: completed.
02
Drugs
fiboflapon
03
Conditions
asthma
Beyond the preview
Go deeper on NCT01471665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01471665.